The Latest Breaking News from AmerisourceBergen Corporation

3 Stocks to Buy With Great Sentiment

Fed ‘pause’ on interest rate hikes is doubtful after recent solid economic data. The increasing rate-hike speculation and other macroeconomic headwinds are expected to keep the stock market highly volatile in the near term. Hence, it could be wise to invest in fundamentally sound stocks ABB (ABBNY), AmerisourceBergen (ABC), and…

StockNews.com · May 30, 2023

Top 3 Health-Tech Stocks to Buy Now

Technology advances are changing how healthcare services are delivered. Here are three health-tech stocks, McKesson (MCK), AmerisourceBergen (ABC), and Cardinal Health (CAH), which could be worth adding to your portfolio. Read more.

StockNews.com · May 9, 2023

4 Medical Stocks That Could Help the Health of Investors’ Portfolios

The healthcare sector often fares well during difficult times due to the constant need for its goods and services. Therefore, quality medical stocks Novo Nordisk (NVO), AmerisourceBergen (ABC), Cardinal Health (CAH), and Haemonetics (HAE) might be the best investments for investors’ portfolios given current macroeconomic headwinds. Read on….

StockNews.com · Mar 27, 2023

2 Growth Stocks Ready to Skyrocket Higher

The Fed’s tightening monetary policy raises concerns that the economy might be on the cusp of a recession. However, robust corporate earnings this season is providing some relief in the gloomy outlook. Given this scenario, here are two growth stocks, AmerisourceBergen (ABC) and Civeo (CVEO), which have demonstrated stable momentum…

StockNews.com · Aug 3, 2022

3 Low-Beta Stocks to Buy to Combat a Jittery Market

The Fed’s aggressive interest rate increases to tame multi-decade high inflation, and an anticipated economic slowdown, have exacerbated market volatility of late. To protect against the market uncertainties, we think investors should consider investing in low-beta stocks Merck (MRK), Gilead Sciences (GILD), and AmerisourceBergen (ABC). Let’s discuss why.

StockNews.com · May 25, 2022

Why Cramer Recommends Buying AECOM, But Suggests Caution On Black Knight

On CNBC’s "Mad Money Lightning Round," Jim Cramer said he likes AmerisourceBergen Corporation (NYSE: ABC) very much as it’s a very "inexpensive, terrific, profitable company."

Benzinga · May 11, 2022

4 Medical Distributor Stocks That Deserve a Place in Your Portfolio

The rising demand for drugs and other medical products over the past few years has significantly increased the importance of healthcare distributors. Furthermore, the adoption of advanced and emerging technologies in the healthcare supply chain should help the medical distribution market grow robustly. So, we think the shares of fundamentally…

StockNews.com · Apr 26, 2022

3 Rock-Solid Dividend Growth Stocks to Fortify Your Portfolio

Market volatility is rising amid the Federal Reserve’s decision to move aggressively with interest rates increases to combat inflation, and the Russia-Ukraine war, raising concerns that the economic recovery may slow. Given the heightened volatility, we think dividend stocks AmerisourceBergen (ABC), EOG Resources (EOG), and Archer-Daniels-Midland (ADM) could be solid…

StockNews.com · Apr 7, 2022

3 Healthcare Stocks to Buy for the Long Run

The healthcare industry has achieved significant growth over the past two years in-part because the COVID-19 pandemic fostered a stream of hefty private and federal investments in the sector. With accelerating advancement and increased tech integration in healthcare, we expect renowned companies Pfizer Inc. (PFE), Merck & Co., Inc. (MRK),…

StockNews.com · Mar 29, 2022

2 Medical Distribution Stocks Surging to New Highs with More Room to Run

The healthcare industry is expected to grow significantly, driven by the sustained demand from an aging population, advancements in medical technologies, and increased health awareness among individuals. Thus, we think it could be wise to invest in the fundamentally strong medical distribution stocks AmerisourceBergen (ABC) and Henry Schein (HSIC) with…

StockNews.com · Mar 22, 2022